Back to search page

TRUK20180319002

A Scottish (UK) Biomaterials SME seeks European partners for product validation and future collaborations

TECHNOLOGY PROFILE   REQUEST   ADD TO FAVOURITES
PRINT

 

ABSTRACT

A UK biomaterials SME has developed novel peptide hydrogels that can be modified to mimic different tissues and provide a cost-effective, animal free 3D matrix to support a range of cell culture applications. The company is looking for partners in the fields of 3D cell culture, assay development, cosmetic/ pharmaceutical testing, and bioprinting to build up new application case studies/ assessments under Research or Technical cooperation agreements, potentially to further collaboration.


FULL DESCRIPTION

The UK-based SME seeking partners is a 3D biomaterials company with a core expertise in the development and manufacture of synthetic 3D peptide hydrogels. These novel patented 3D peptide hydrogels can be chemically and mechanically modified to mimic different tissues and provide a cost effective, animal free 3D matrix to support a range of exciting high growth applications including;
3D Cell Culture
3D Bioprinting
Tissue Engineering & Regeneration
In vitro Models for Drug and Cosmetic Screening
Drug Delivery

The hydrogel technology has been shown to promote cell adhesion, growth and proliferation in a range of applications, with current programmes indicating success with a variety of cell types including stem cells, neuronal cells, keratinocytes, and hepatocytes. The materials are currently being used in the study of diseases such as osteoarthritis and cancer, as well as the development of skin models and spinal cord repair treatments.

The key advantages of the SME's hydrogel technology are that the materials are:
Fully synthetic - They contain no animal-derived material, but are composed of biologically relevant peptides which display consistent physical properties when manufactured.
Totally Tuneable - Stiffness and chemistry environment can be tuned to match cell environment.
Flexible Handling - Provided as a powder. Culture media induces gelation, no temperature or pH dependence. They are injectable.

The SME possesses significant expertise in the manufacture and formulation development of peptide hydrogels and has the capabilities to design and develop bespoke formulations to meet clients' specific requirements. In order to validate its hydrogel technology as an effective synthetic 3D matrix for a variety of cell culture applications, the company is seeking partners in the areas of cell culture, in vitro assays, and bioprinting who wish to develop more physiologically relevant in vitro models, who require an alternative 3D matrix/ scaffold to that which they are currently using or are developing a new application in which a hydrogel scaffold would be beneficial.

The SME will provide its expertise, guidance and technical support to help partners to validate the hydrogel technology in their specific application. The partner company should be able to provide feedback on the performance of the hydrogel technology compared with their traditional methods.

Initial cooperation would be under a Research or Technical Cooperation Agreement and should new development opportunities arise as a result of the cooperation, further collaborative funding applications and joint ventures may be possible.


Partner expertise sought:

- Type of partner sought: The SME is looking for industry or academic partners with expertise in cell culture. In particular, those focused on the development of 3D models for the testing of pharmaceuticals or cosmetics and those involved in bioprinting.

The SME's hydrogel technology would be of specific interest to partners wishing to:
- develop more physiologically relevant 3D culture models
- replace currently used animal-derived 3D matrices with a synthetic, biologically relevant alternatives
- develop optimal 3D culture conditions for specific cell types
- find a synthetic bio-ink
- Specific area of activity of the partner: The SME is looking for industry or academic partners with expertise in cell culture. In particular those focused on the development of 3D models for the testing of pharmaceuticals or cosmetics and those involved in bioprinting.

The SME's hydrogel technology would be of specific interest to partners wishing to:
- develop more physiologically relevant 3D culture models
- replace currently used animal-derived 3D matrices with a synthetic, biologically relevant alternatives
- develop optimal 3D culture conditions for specific cell types
- find a synthetic bioink

The SME will provide its expertise, guidance and technical support to help partners to validate the hydrogel technology in their specific application. The partner company should be able to provide feedback on the performance of the hydrogel technology compared their traditional methods to allow the SME to assess the materials performance in the specific application and generate case studies.

It is envisioned that initial cooperation would be under a Research or Technical cooperation agreement. Should new development opportunities arise as a result of the cooperation, further collaborative funding applications and joint ventures may be possible.

Sign-in or create an account

To express an interest in this profile, you must first sign in or create a new account.

If you already have an account, sign in here

Not got an account yet, sign up here

KEY INFORMATION

Country of origin
UNITED KINGDOM
Profile date
26/03/2018
Deadline
27/03/2019

PARTNERSHIP(S) SOUGHT

Technical cooperation agreement Research cooperation agreement

CLASSIFICATIONS

INDUSTRY SECTORS
Life Sciences \ Biosciences and Health \ Drug Discovery and Drug Development \ Diagnostics
TECHNOLOGY KEYWORDS
BIOLOGICAL SCIENCES / Biology / Biotechnology / Cellular and Molecular Biology / BIOLOGICAL SCIENCES / Biology / Biotechnology / In vitro Testing, Trials / BIOLOGICAL SCIENCES / Biology / Biotechnology / Toxicology
COMMERCIAL KEYWORDS
Research and experimental development on biotechnology
MARKET KEYWORDS
GENETIC ENGINEERING/MOLECULAR BIOLOGY / Cellular and Molecular Biology / GENETIC ENGINEERING/MOLECULAR BIOLOGY / In vitro Testing, Trials / GENETIC ENGINEERING/MOLECULAR BIOLOGY / Toxicology / GENETIC ENGINEERING/MOLECULAR BIOLOGY / Stem cells and biobanks

FIND OUT MORE

Contact Enterprise Europe Network Scotland by email at info@enterprise-europe-scotland.com, quoting reference number TRUK20180319002